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Background
In HIV-1/HTLV-2 co-infected IDUs the CCL3/MIP-1alpha
induction by HTLV-2 leads to HIV inhibition. CCL3 gene
codes for CCL3/LD78alpha and CCL3L1/LD78beta iso-
forms. CCL3L1 binds more potently to CCR5 than any
other chemokine. Possession of a CCL3L1 copy number
lower than two (the population average for Europeans) is
associated with markedly enhanced HIV/AIDS suscepti-
bility. Here, we analysed the genotype frequency of
CCL3L1 and its expression in 8 HTLV-2-infected/HIV-1-
exposed-seronegative (HTLV-2/HIV-1ESN) individuals, 7
LTNP-HIV-1/HTLV-2-co-infected and 8 LTNP-HIV-1-
mono-infected subjects.
Methods
R5 HIV-1 infection of PBMC from HTLV-2/HIV-1ESN was
evaluated for HIV proviral load and for p24 production.
CCL3L1 gene copy number and mRNA expression levels
were assessed using real-time PCR. CCL3 and CCL3L1 iso-
forms were identified from spontaneous PBMC cultures
by mass spectrometry (MS).
Results
R5 infectibility and efficiency of viral replication in pri-
mary PBMC from HTLV-2/HIV-1ESN were very low. The
median of CCL3L1 copy number was one in HTLV-2/HIV-
1ESN, three in LTNP-HIV-1 and two in HIV-1/HTLV-2 sub-
jects. CCL3-L1 mRNA was more abundant in individuals
with HTLV-2 infection than in HIV-1 LTNPs. MS analysis
evidenced that intact CCL3L1, usually not secreted from
healthy subjects, was produced by PBMC of HTLV-2/HIV-
1ESN. Noteworthy, CCL3L1 isoform was highly expressed
by PBMC of LTNP HIV-1/HTLV-2, but not of HIV-1
LTNPs. The high CCL3L1 production, and a persistent
IFN-gamma secretion, conferred a CCR5low phenotype to
HTLV-2 infected subjects.
Conclusion
HTLV-2 may curtail HIV-1 infection upregulating the
CCL3L1/LD78beta chemokine. Apparently, HTLV-2 infec-
tion can fully compensate for the functional state con-
ferred by CCL3L1low.
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